2025年2月3日 · Journavx (suzetrigine) is a new non-opioid pain-relieving tablet used to treat short-term (acute) moderate to severe pain. Journavx is a sodium channel blocker that relieves pain by blocking pain-sensing nerves around the body from transmitting pain messages to the spinal cord and brain.

2025年1月30日 · Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults.

Ask your doctor about JOURNAVX, an oral medication that reduces pain signals before they reach the brain. a Acute pain is a type of pain that starts suddenly and lasts less than 3 months. It's often caused by an injury or surgery.

JOURNAVX is a sodium channel blocker indicated for the treatment of moderate to severe acute pain in adults. (1) Recommended starting JOURNAVX oral dose is 100 mg. Take the starting dose on an...

See information for healthcare professionals on JOURNAVX, a nonopioid treatment for moderate-to-severe acute pain in adults. See Important Safety Information and Prescribing Information.

2025年1月31日 · Journavx has a list price of $15.50 per pill, which is significantly more expensive than comparable opioids. However, it’s unclear to what extent insurers could cover the medicine, and patient ...

2025年1月31日 · Journavx, Vertex's new non-opioid painkiller, is an alternative for managing moderate-to-severe acute pain without the risk of addiction. Clinical trials showed it provides similar pain relief to opioids, but with fewer side effects.

2025年1月30日 · A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

Journavx is an effective, well-tolerated medicine without evidence of addictive potential indicated for use across all types of moderate-to-severe acute pain.

2025年1月31日 · For the first time in 25 years, the U.S. Food and Drug Administration has approved a new type of painkiller. Suzetrigine, sold as Journavx, is administered twice daily in 50-milligram oral...